Increasing efficiency not only leads to economic growth and optimal use of existing resources. It is also an essential component of competitiveness. Automation solutions are therefore more in demand than ever.
For example, digitized cell line development and production is also one of the guarantors of greater efficiency in the pharmaceutical industry. Here, the guideline of the U.S. Food and Drug Administration (FDA) 21 CFR Part 11, on "Electronic Records and Electronic Signatures," enables the transition from paper-based manual processes to computer-supported electronic processes.
This requires working with 21 CFR part 11 compliant software, such as SYNENTECS' newly developed YT-AUDIT Imaging and validation software.